SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN THE STATEMENTS FILED
PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO
FILED PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)*
GENEREX BIOTECHNOLOGY CORPORATION
----------------------------
(Name of Issuer)
Common Stock, par value $0.001 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
371485103
--------------
(CUSIP Number)
December 31, 2002
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
CUSIP NO. 371485103 Page 2 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Protius Overseas Limited
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Isle of Man
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 1,219,600 (See Item 4)
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 1,219,600 (See Item 4)
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,219,600 (See Item 4)
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.89%(See Item 4)
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 371485103 Page 3 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Cranshire Capital, L.P.
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 1,219,600 (See Item 4)
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 1,219,600 (See Item 4)
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,219,600 (See Item 4)
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.89%(See Item 4)
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
PN
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 371485103 Page 4 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Downsview Capital, Inc.
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 1,219,600 (See Item 4)
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 1,219,600 (See Item 4)
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,219,600 (See Item 4)
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.89%(See Item 4)
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 371485103 Page 5 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
JMJ Capital, Inc.
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 1,219,600 (See Item 4)
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 1,219,600 (See Item 4)
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,219,600 (See Item 4)
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.89%(See Item 4)
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 371485103 Page 6 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
EURAM Cap Strat. "A" Fund Limited
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 1,219,600 (See Item 4)
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 1,219,600 (See Item 4)
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,219,600 (See Item 4)
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.89%(See Item 4)
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 371485103 Page 7 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Mitchell P. Kopin
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 1,219,600 (See Item 4)
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 1,219,600 (See Item 4)
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,219,600 (See Item 4)
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.89%(See Item 4)
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 371485103 Page 8 of 10
Item 1(a). Name of Issuer:
Generex Biotechnology Corporation (the "Issuer")
Item 1(b). Address of Issuer's Principal Executive Offices:
33 Harbour Square, Suite 202
Toronto, Ontario, Canada M5J 2G2
Items 2(a), Name of Persons Filing, Address of Principal Business Office and
(b) and Citizenship:
(c).
This Schedule 13G is being filed on behalf of (i) Protius Overseas
Limited, an Isle of Man limited company ("Protius"), (ii) Cranshire
Capital, L.P., an Illinois limited parternship ("Cranshire"), (iii)
Downsview Capital, Inc., an Illinois corporation ("Downsview"), (iv)
JMJ Capital, Inc., an Illinois corporation ("JMJ"), (v) EURAM Cap
Strat. "A" Fund Limited, a Cayman Islands exempted company ("EURAM")
and (vi) Mitchell P. Kopin, a United States citizen ("Kopin," together
with Protius, Cranshire, Downsview, JMJ and EURAM, the "Reporting
Persons").
The principal business office of Protius is P.O. Box 17512-14, Finch
Road Douglas, Isle of Man, IM99. The principal business office of each
of the other Reporting Persons is 666 Dundee Road, Suite 1901,
Northbrook, Illinois, 60062.
Item 2(d). Title of Class of Securities:
Common Stock, par value $.001 per share, of the Issuer (the "Common
Stock")
Item 2(e). CUSIP Number:
371485103
Item 3. Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned:
1,219,600 shares of Common Stock*
(b) Percent of class:
Based on 20,693,434 shares of Common Stock of the Issuer outstanding
as of October 31, 2002 (as set forth in the Issuer's Form 10-Q for the
period ended October 31, 2002), the Reporting Persons hold
approximately 5.89%* of the issued and outstanding Common Stock of the
Issuer. The shares of Common Stock reported in this Schedule 13G
include 80,012 shares of Common Stock issuable upon the exercise of
warrants held by Cranshire.
SCHEDULE 13G
CUSIP NO. 371485103 Page 9 of 10
(c) Number of shares to which such person has:
(i) Sole power to vote or direct the vote: 0
(ii) Shared power to vote or direct the vote: 1,219,600*
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose of or direct the disposition of:
1,219,600*
*The beneficial ownership reported by the Reporting Persons excludes
certain warrants held by Protius which Protius is contractually
restricted from exercising at this time. Protius cannot exercise such
warrants so long as the Reporting Persons would be deemed "beneficial
owners" of more than 4.9% of the Common Stock following such
conversion.
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported By the Parent Holding Company.
Not applicable
Item 8. Identification and Classification of Members of the Group.
Not applicable
Item 9. Notice of Dissolution of a Group.
Not applicable
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
SCHEDULE 13G
CUSIP NO. 371485103 Page 10 of 10
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 6, 2003
PROTIUS OVERSEAS LIMITED
By: /s/ Gordon J. Mundy
-----------------------------
Gordon J. Mundy
CRANSHIRE CAPITAL, L.P.
By: Downsview Capital, Inc.,
its General Partner
By:/s/ Mitchell P. Kopin
------------------------------
Mitchell P. Kopin, President
DOWNSVIEW CAPITAL, INC.
By:/s/ Mitchell P. Kopin
-------------------------------
Mitchell P. Kopin, President
EURAM CAP STRAT. "A" FUND LIMITED
By: JMJ Capital, Inc.,
its Investment Manager
By:/s/ Mitchell P. Kopin
------------------------------
Mitchell P. Kopin, President
JMJ CAPITAL, INC.
By:/s/ Mitchell P. Kopin
------------------------------
Mitchell P. Kopin, President
/s/ Mitchell P. Kopin
--------------------------------
Mitchell P. Kopin